scibac Stock

SciBac is a Biotechnology company which creates rEvolutionary live biotherapeutics.

Founded

2015

Headquarters

Burlingame CA, US

Total Funding

$3.8M

About scibac Stock

Funding History

July 2018	$3.8M

Other Companies

Learn More

Elysium Health

Scientific health products

$29.3MTotal Funding

Learn More

Harpoon Therapeutics

Harpoon Therapeutics is a preclinical stage biotechnology company.

$130MTotal Funding

Learn More

Solugen

Solugen has developed a unique process for the synthesis of hydrogen peroxide inspired by principles of cancer biology.

$36.7MTotal Funding

Learn More

Sonder

Sonder is High-Est Quality Cannabis Extracts Sun-Grown .

$250KTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from scibac or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.